355 related articles for article (PubMed ID: 21178122)
21. Regulation of low-density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase expression by Zingiber officinale in the liver of high-fat diet-fed rats.
Nammi S; Kim MS; Gavande NS; Li GQ; Roufogalis BD
Basic Clin Pharmacol Toxicol; 2010 May; 106(5):389-95. PubMed ID: 20002065
[TBL] [Abstract][Full Text] [Related]
22. Modulation of rat liver 3-hydroxy-3-methylglutaryl-CoA reductase activity by reversible phosphorylation.
Beg ZH; Brewer HB
Fed Proc; 1982 Aug; 41(10):2634-8. PubMed ID: 6286363
[TBL] [Abstract][Full Text] [Related]
23. In vivo modulation of rat liver 3-hydroxy-3-methylglutaryl-coenzyme A reductase, reductase kinase, and reductase kinase kinase by mevalonolactone.
Beg ZH; Stonik JA; Brewer HB
Proc Natl Acad Sci U S A; 1984 Dec; 81(23):7293-7. PubMed ID: 6594693
[TBL] [Abstract][Full Text] [Related]
24. Effect of endotoxin on cholesterol biosynthesis and distribution in serum lipoproteins in Syrian hamsters.
Feingold KR; Hardardottir I; Memon R; Krul EJ; Moser AH; Taylor JM; Grunfeld C
J Lipid Res; 1993 Dec; 34(12):2147-58. PubMed ID: 8301233
[TBL] [Abstract][Full Text] [Related]
25. Effects of HMG-CoA reductase inhibition on hepatic expression of key cholesterol-regulatory enzymes and receptors in nephrotic syndrome.
Vaziri ND; Liang K
Am J Nephrol; 2004; 24(6):606-13. PubMed ID: 15583480
[TBL] [Abstract][Full Text] [Related]
26. Inhibitors of sterol synthesis. Effects of dietary 5 alpha-cholest-8(14)-en-3 beta-ol-15-one on early enzymes in hepatic cholesterol biosynthesis.
Miller LR; Raulston DL; Schroepfer GJ
Chem Phys Lipids; 1988 Jul; 47(3):177-86. PubMed ID: 2901919
[TBL] [Abstract][Full Text] [Related]
27. Reduction of oxysterol levels up-regulates HMG-CoA reductase activity in rat liver.
Tamasawa N; Hayakari M; Murakami H; Matsui J; Suda T
Atherosclerosis; 1997 Jun; 131(2):237-42. PubMed ID: 9199277
[TBL] [Abstract][Full Text] [Related]
28. Discordant regulation of proteins of cholesterol metabolism during the acute phase response.
Feingold KR; Pollock AS; Moser AH; Shigenaga JK; Grunfeld C
J Lipid Res; 1995 Jul; 36(7):1474-82. PubMed ID: 7595071
[TBL] [Abstract][Full Text] [Related]
29. Compensatory responses to inhibition of hepatic squalene synthase.
Lopez D; Chambers CM; Keller RK; Ness GC
Arch Biochem Biophys; 1998 Mar; 351(2):159-66. PubMed ID: 9514656
[TBL] [Abstract][Full Text] [Related]
30. Phosphorylation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase and modulation of its enzymic activity by calcium-activated and phospholipid-dependent protein kinase.
Beg ZH; Stonik JA; Brewer HB
J Biol Chem; 1985 Feb; 260(3):1682-7. PubMed ID: 3155737
[TBL] [Abstract][Full Text] [Related]
31. Policosanol Attenuates Cholesterol Synthesis via AMPK Activation in Hypercholesterolemic Rats.
Nam DE; Yun JM; Kim D; Kim OK
J Med Food; 2019 Nov; 22(11):1110-1117. PubMed ID: 31613687
[TBL] [Abstract][Full Text] [Related]
32. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts by reversible phosphorylation: modulation of enzymatic activity by low density lipoprotein, sterols, and mevalonolactone.
Beg ZH; Reznikov DC; Avigan J
Arch Biochem Biophys; 1986 Jan; 244(1):310-22. PubMed ID: 3004340
[TBL] [Abstract][Full Text] [Related]
33. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.
Reihnér E; Rudling M; Ståhlberg D; Berglund L; Ewerth S; Björkhem I; Einarsson K; Angelin B
N Engl J Med; 1990 Jul; 323(4):224-8. PubMed ID: 2114543
[TBL] [Abstract][Full Text] [Related]
34. Homocysteine thiolactone-induced hyperhomocysteinemia does not alter concentrations of cholesterol and SREBP-2 target gene mRNAS in rats.
Stangl GI; Weisse K; Dinger C; Hirche F; Brandsch C; Eder K
Exp Biol Med (Maywood); 2007 Jan; 232(1):81-7. PubMed ID: 17202588
[TBL] [Abstract][Full Text] [Related]
35. Farnesol is not the nonsterol regulator mediating degradation of HMG-CoA reductase in rat liver.
Keller RK; Zhao Z; Chambers C; Ness GC
Arch Biochem Biophys; 1996 Apr; 328(2):324-30. PubMed ID: 8645011
[TBL] [Abstract][Full Text] [Related]
36. Feeding status-related effects of 17 beta-estradiol on liver 3-hydroxy-3-methylglutaryl CoA reductase.
Alonso MA; Fernandez de Quincoces A; Lacort M; Gandarias JM; Ochoa B
Exp Clin Endocrinol; 1993; 101(3):123-30. PubMed ID: 8223979
[TBL] [Abstract][Full Text] [Related]
37. Gonadotropin modulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in desensitized luteinized rat ovary.
Azhar S; Chen YD; Reaven GM
Biochemistry; 1984 Sep; 23(20):4533-8. PubMed ID: 6437439
[TBL] [Abstract][Full Text] [Related]
38. Effect of removal of lipoproteins of different composition on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and hepatic very low density lipoprotein secretion.
Van Zuiden PE; Erickson SK; Cooper AD
J Lipid Res; 1983 Apr; 24(4):418-28. PubMed ID: 6854151
[TBL] [Abstract][Full Text] [Related]
39. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase activity is inhibited by cholesterol and up-regulated by sitosterol in sitosterolemic fibroblasts.
Honda A; Salen G; Honda M; Batta AK; Tint GS; Xu G; Chen TS; Tanaka N; Shefer S
J Lab Clin Med; 2000 Feb; 135(2):174-9. PubMed ID: 10695663
[TBL] [Abstract][Full Text] [Related]
40. Diabetes increases hepatic hydroxymethyl glutaryl coenzyme A reductase protein and mRNA levels in the small intestine.
Feingold KR; Wilson DE; Wood LC; Kwong LK; Moser AH; Grunfeld C
Metabolism; 1994 Apr; 43(4):450-4. PubMed ID: 8159102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
